World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
55980
World Ranking
13839
National Ranking
7024

Benjamin Djulbegovic publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Benjamin Djulbegovic sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 507 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Benjamin Djulbegovic D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Benjamin Djulbegovic sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Benjamin Djulbegovic is affiliated with the City Of Hope National Medical Center in the United States. Their research primarily focuses on medicine, with significant contributions in economics, econometrics, and finance. Within these broader areas, their subfield expertise includes economics and econometrics, public health, environmental and occupational health, general health professions, statistics, probability and uncertainty, and oncology.

The scientist's work addresses several key topics, including health systems, economic evaluations, and quality of life; meta-analysis and systematic reviews; clinical practice guidelines implementation; healthcare cost, quality, and practices; venous thromboembolism diagnosis and management; statistical methods in clinical trials; and advanced causal inference techniques.

Benjamin Djulbegovic has published in numerous academic venues, with the highest number of publications appearing in these journals:

  • Journal of Clinical Epidemiology (18 publications)
  • Journal of Evaluation in Clinical Practice (13 publications)
  • Blood Advances (11 publications)
  • Cancer Treatment and Research (9 publications)
  • Blood (6 publications)

Their recent papers include:

  • Older adult participation in cancer clinical trials: A systematic review of barriers and interventions (2020) in CA A Cancer Journal for Clinicians
  • GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making (2020) in Journal of Clinical Epidemiology
  • Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review (2020) in Journal of Clinical Oncology
  • Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors (2020) in JAMA Oncology
  • Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis (2021) in BMJ

Benjamin Djulbegovic has collaborated frequently with several coauthors, including:

  • Iztok Hozo, with 46 joint publications
  • Gordon Guyatt, with 23 joint publications
  • Liang Yao, with 7 joint publications
  • Elie A. Akl, with 6 joint publications
  • Adam Cuker, with 6 joint publications

In book publications, Djulbegovic has contributed to scientific literature through at least one book published by Springer Science+Business Media titled Threshold Decision-making in Clinical Medicine (2023).

Best Publications

  • Estimating the mean and variance from the median, range, and the size of a sample.

    Stela Pudar Hozo;Benjamin Djulbegovic;Iztok Hozo

  • GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

    Gordon H. Guyatt;Andrew D. Oxman;Gunn Vist;Regina Kunz

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Pharmaceutical industry sponsorship and research outcome and quality: systematic review

    Joel Lexchin;Lisa A Bero;Benjamin Djulbegovic;Otavio Clark

  • GRADE guidelines: 5. Rating the quality of evidence--publication bias

    Gordon H. Guyatt;Andrew D. Oxman;Victor Manuel Montori;Gunn Vist

  • How to increase value and reduce waste when research priorities are set

    Iain Chalmers;Michael B Bracken;Ben Djulbegovic;Silvio Garattini

  • GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

    Jeffrey C. Andrews;Holger J. Schünemann;Andrew D. Oxman;Kevin Pottie

  • Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*

    Jeffrey L. Carson;Brenda J. Grossman;Steven Kleinman;Alan T. Tinmouth

  • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.

    J. Douglas Rizzo;Alan E. Lichtin;Steven H. Woolf;Jerome Seidenfeld

  • Recommendations on the Use of 18F-FDG PET in Oncology

    James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

    John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda

  • Platelet Transfusion: A Clinical Practice Guideline From the AABB

    Richard M. Kaufman;Benjamin Djulbegovic;Terry Gernsheimer;Steven Kleinman

  • Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

    Charles L. Bennett;Samuel M. Silver;Benjamin Djulbegovic;Athena T. Samaras

  • Progress in evidence-based medicine: a quarter century on.

    Benjamin Djulbegovic;Benjamin Djulbegovic;Gordon H Guyatt

  • Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Richard I. Fisher;Steven H. Bernstein;Brad S. Kahl;Benjamin Djulbegovic

  • GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.

    Gordon H. Guyatt;Andrew D. Oxman;Nancy Santesso;Mark Helfand

  • Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients

    Julia Bohlius;Jayne Wilson;Jerome Seidenfeld;Margaret Piper

  • Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

    Julia Bohlius;Kurt Schmidlin;Corinne Brillant;Guido Schwarzer

  • The uncertainty principle and industry-sponsored research

    Benjamin Djulbegovic;Mensura Lacevic;Alan Cantor;Karen K Fields

  • Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

    Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

Frequent Co-Authors

Gordon H. Guyatt
Gordon H. Guyatt McMaster University
Gary H. Lyman
Gary H. Lyman Fred Hutchinson Cancer Research Center
Charles L. Bennett
Charles L. Bennett University of South Carolina
Holger J. Schünemann
Holger J. Schünemann Humanitas University
Mike Clarke
Mike Clarke Queen's University Belfast
Keith Wheatley
Keith Wheatley University of Birmingham
Elie A. Akl
Elie A. Akl American University of Beirut
Alan F. List
Alan F. List Precision BioSciences
Paul Glasziou
Paul Glasziou Bond University
Iain Chalmers
Iain Chalmers University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in launching or advancing a medical career, but not ready for the full commitment of a U.S. medical degree? There are many flexible and affordable online options to consider. For those looking to enter nursing quickly, lpn programs offer a fast-track route to start working as a licensed practical nurse.

If you’re passionate about mental health, psychiatric np programs allow nurses to specialize in psychiatric care and support patients with a range of mental health needs.

For those interested in leadership, a cheapest online healthcare administration degree helps students develop the management skills needed to oversee clinics, hospitals, or medical practices. Those seeking advanced roles can also explore the cheapest online mha programs, which further boost career prospects in healthcare management.

These pathways are ideal for students looking for flexibility, affordability, and quick entry into various healthcare roles, making them strong alternatives or complements to traditional medical education.

Best Scientists Citing Benjamin Djulbegovic

Trending Scientists

Recently Published Articles